Business Context and Reporting Period
Archimedes Tech SPAC Partners III Co., a Cayman Islands emerging growth company, filed this Form 8-K on January 26, 2026, to report the consummation of its initial public offering (IPO). The company trades on The Nasdaq Stock Market under the symbols ARCIU (Units), ARCI (Ordinary Shares), and ARCIW (Warrants).
Key Financial Metrics
- IPO Gross Proceeds: $276,000,000 from the sale of 27,600,000 Units at $10.00 per Unit (including full exercise of the 3,600,000 Unit over-allotment).
- Private Placement Proceeds: $7,620,000 from the sale of 762,000 private units to the Sponsor and BTIG, LLC at $10.00 per unit.
- Total Capital Raised: $283,620,000.
- Trust Account Balance: $276,000,000 deposited as of January 26, 2026, for the benefit of public shareholders.
- Warrant Exercise Price: $11.50 per share (subject to adjustment).
- Revenue, Profit, and Cash Flow: The filing text does not provide operating revenue, net income, or operating cash flow figures, as this is a pre-operational SPAC IPO filing.
- Debt and Liquidity: Specific debt obligations are not detailed in this excerpt; liquidity is primarily represented by the trust account balance.
Material Changes
This filing represents the company's transition from a private entity to a publicly traded corporation. The material change is the successful closing of the IPO and the simultaneous private placement, resulting in the establishment of a $276 million trust account. There is no prior comparable period for financial performance as the company has not yet commenced operations.
Guidance, Outlook, and Risks
The filing confirms the completion of the capital raise but does not provide specific financial guidance, earnings outlook, or management commentary regarding future business targets. The primary contingency noted is the standard SPAC structure where proceeds are held in trust pending a business combination. The filing includes a Balance Sheet dated January 26, 2026, as an exhibit.
Investor Verification Checklist
- Verify the final underwriting fees and expenses deducted from the gross proceeds to determine the actual net cash available outside the trust.
- Confirm the specific terms of the private placement units, including any redemption rights or restrictions compared to public units.
- Review the full Balance Sheet (Exhibit 99.1) to assess any initial liabilities or working capital deficits outside the trust account.
- Monitor the timeline for the company to identify and consummate a target business combination.